For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241008:nRSH4208Ha&default-theme=true
RNS Number : 4208H Advanced Oncotherapy PLC 08 October 2024
ADVANCED ONCOTHERAPY PLC - IN ADMINISTRATION
("Advanced Oncotherapy" or the "Company")
Confirmation of Conclusion of Formal Sale Process
Further to the announcement dated 18 April 2023 commencing a Formal Sale
Process under the City Code on Takeovers and Mergers by the Company (the
"FSP"), David Hudson and Ian Corfield of FRP Advisory, Administrators of the
Company, confirm that Advanced Oncotherapy is no longer undertaking its FSP,
as a result of the Company entering into Administration on 30 May 2024.
Accordingly, the Company is no longer in an offer period and the requirement
to make disclosures under Rule 8 of the Takeover Code has ceased.
David Hudson
Joint Administrator Tel: +44 (0) 30005 4000
The Joint Administrators act as agents of the Company without personal
liability
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAEASEPELXLFFA